Preoperative Serum IL6, IL8, and TNF-α May Predict the Recurrence of Hepatocellular Cancer
Table 1
Demographics and baseline characteristics of the patients from the recurrence group and the nonrecurrence group.
Factor
Recurrence group ()
Nonrecurrence group ()
value
Age (year)
0.124
Male/female
74/14
55/14
0.477
Tumor size (cm)
<0.001
MVI (present/absent)
52/36
29/40
0.034
Child-Pugh, A/B
84/4
65/4
0.732
Differentiation (poor/well)
32/56
17/52
0.116
Cirrhosis, yes/no
65/23
51/18
0.994
HBsAg, yes/no
58/30
46/23
0.921
AFP
113.5 (13.9-1434.3)
150.0 (21.9-627.2)
0.857
BMI
0.984
ALT
48.3 (24.7-87.1)
32.4 (22.2-627.2)
0.157
AST
44.1 (24.0-102.7)
31.2 (20.1-59.9)
0.052
TBIL
14.7 (10.3-21.8)
14.2 (10.8-17.4)
0.278
Operative procedure
0.992
Extended hemihepatotectomy
5
5
Hemihepatotectomy
11
9
Sectionectomy
25
20
Segmentectomy
9
6
Laparoscopic approach
38
29
Pringle maneuver
50/38
42/27
0.609
Operative time (min)
240.0 (200.0-293.8)
255.0 (200.0-285.0)
0.479
Total blood loss (ml)
500.0 (212.5-700.0)
400.0 (200.0-600.0)
0.226
Note: data are presented as the median (IQR) or . Abbreviations: BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; AFP: α-fetoprotein; TBIL: total bilirubin; HBsAg: hepatitis B virus surface antigen; MVI: microvascular invasion.
